Literature DB >> 20199761

Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.

V L Fowler1, N J Knowles, D J Paton, P V Barnett.   

Abstract

Previous work in cattle and pigs demonstrated that protection against foot-and-mouth disease (FMD) could be achieved following vaccination with chimeric foot-and-mouth disease virus (FMDV) vaccines, in which the VP1 G-H loop had been substituted with that from another serotype. This indicated that the VP1 G-H loop may not be essential for the protection of natural hosts against FMDV. If this could be substantiated there would be potential to develop FMD marker vaccines, characterised by the absence of this region. Here, we investigate the serological responses to vaccination with a virus with a partial VP1 G-H loop deletion in order to determine the likelihood of achieving protection and the potential of this virus as a marker vaccine. Inactivated, oil adjuvanted, vaccines, consisting of chemically inactivated virus with or without a partially deleted VP1 G-H loop, were used to immunise cattle. Serum was collected on days 0, 7, 14 and 21 and antibody titres calculated using the virus neutralisation test (VNT) to estimate the likelihood of protection. We predict a good likelihood that cattle vaccinated with a vaccine characterised by a partial VP1 G-H loop would be protected against challenge with the same virus containing the VP1 G-H loop. We also present evidence on the potential of such a construct to act as a marker vaccine, when used in conjunction with a novel serological test. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20199761     DOI: 10.1016/j.vaccine.2010.02.074

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  Xenoepitope substitution avoids deceptive imprinting and broadens the immune response to foot-and-mouth disease virus.

Authors:  Steven M Szczepanek; Roger W Barrette; Debra Rood; Diana Alejo; Lawrence K Silbart
Journal:  Clin Vaccine Immunol       Date:  2012-02-08

2.  The C3d-fused foot-and-mouth disease vaccine platform overcomes maternally-derived antibody interference by inducing a potent adaptive immunity.

Authors:  Min Ja Lee; Hyun Mi Kim; Sehee Shin; Hyundong Jo; So Hui Park; Su-Mi Kim; Jong-Hyeon Park
Journal:  NPJ Vaccines       Date:  2022-06-28       Impact factor: 9.399

3.  High-yield production of the VP1 structural protein epitope from serotype O foot-and-mouth disease virus in Escherichia coli.

Authors:  Joon-Goo Jung; Yong Jae Lee; Natarajan Velmurugan; Young-Joon Ko; Hyang-Sim Lee; Ki Jun Jeong
Journal:  J Ind Microbiol Biotechnol       Date:  2013-04-26       Impact factor: 3.346

4.  Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics.

Authors:  Pinghua Li; Xingwen Bai; Pu Sun; Dong Li; Zengjun Lu; Yimei Cao; Yuanfang Fu; Huifang Bao; Yingli Chen; Baoxia Xie; Zaixin Liu
Journal:  BMC Vet Res       Date:  2012-05-16       Impact factor: 2.741

5.  A Brief Review on Diagnosis of Foot-and-Mouth Disease of Livestock: Conventional to Molecular Tools.

Authors:  Neeta Longjam; Rajib Deb; A K Sarmah; Tilling Tayo; V B Awachat; V K Saxena
Journal:  Vet Med Int       Date:  2011-07-06

6.  Identification of a novel cell culture adaptation site on the capsid of foot-and-mouth disease virus.

Authors:  Kyle Chamberlain; Veronica L Fowler; Paul V Barnett; Sarah Gold; Jemma Wadsworth; Nick J Knowles; Terry Jackson
Journal:  J Gen Virol       Date:  2015-07-03       Impact factor: 3.891

7.  Artificially designed recombinant protein composed of multiple epitopes of foot-and-mouth disease virus as a vaccine candidate.

Authors:  Ho-Bin Lee; Da-Chuan Piao; Jun-Yeong Lee; Jae-Yun Choi; Jin-Duck Bok; Chong-Su Cho; Sang-Kee Kang; Yun-Jaie Choi
Journal:  Microb Cell Fact       Date:  2017-02-22       Impact factor: 5.328

8.  Identification of a short, highly conserved, motif required for picornavirus capsid precursor processing at distal sites.

Authors:  Thea Kristensen; Graham J Belsham
Journal:  PLoS Pathog       Date:  2019-01-18       Impact factor: 6.823

9.  Evaluation of a 3A-truncated foot-and-mouth disease virus in pigs for its potential as a marker vaccine.

Authors:  Pinghua Li; Zengjun Lu; Xingwen Bai; Dong Li; Pu Sun; Huifang Bao; Yuanfang Fu; Yimei Cao; Yingli Chen; Baoxia Xie; Hong Yin; Zaixin Liu
Journal:  Vet Res       Date:  2014-05-01       Impact factor: 3.683

10.  Immune responses in pigs and cattle vaccinated with half-volume foot-and-mouth disease vaccine.

Authors:  Min-Eun Park; Su-Hwa You; Seo-Yong Lee; Kwang-Nyeong Lee; Mi-Kyeong Ko; Joo-Hyung Choi; Byounghan Kim; Jong-Soo Lee; Jong-Hyeon Park
Journal:  J Vet Sci       Date:  2017-08-31       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.